MENU
TACN
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

TACN stock forecast, quote, news & analysis

The investment seeks to provide long-term capital growth... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for TACN with price predictions
Nov 10, 2026

TACN in downward trend: price dove below 50-day moving average on November 10, 2026

TACN moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend. In 4 of 5 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TACN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.

The Aroon Indicator for TACN entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on TACN as a result. In 12 of 15 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.

The Moving Average Convergence Divergence (MACD) for TACN just turned positive on November 09, 2026. Looking at past instances where TACN's MACD turned positive, the stock continued to rise in 8 of 8 cases over the following month. The odds of a continued upward trend are 90%.

Following a +1.15% 3-day Advance, the price is estimated to grow further. Considering data from situations where TACN advanced for three days, in 34 of 36 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

TACN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are AstraZeneca PLC (NYSE:AZN).

Industry description

The investment seeks to provide long-term capital growth. The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in equity securities, such as common stock. Any derivatives that provide exposure to the investment focus suggested by the fund’s name, or to one or more market risk factors associated with the investment focus suggested by the fund’s name, are counted (as applicable) toward compliance with the fund’s 80% investment policy.

Market Cap

The average market capitalization across the T. Rowe Price Active Core International Equity ETF (TACN) ETF is 137.24B. The market cap for tickers in the group ranges from 3.51M to 547.25B. ASML holds the highest valuation in this group at 547.25B. The lowest valued company is NOVN at 3.51M.

High and low price notable news

The average weekly price growth across all stocks in the T. Rowe Price Active Core International Equity ETF (TACN) ETF was 16%. For the same ETF, the average monthly price growth was 21%, and the average quarterly price growth was 54%. BBVA experienced the highest price growth at 10%, while SHEL experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the T. Rowe Price Active Core International Equity ETF (TACN) ETF was -21%. For the same stocks of the ETF, the average monthly volume growth was 18% and the average quarterly volume growth was -3%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 46
Price Growth Rating: 49
SMR Rating: 45
Profit Risk Rating: 39
Seasonality Score: -1 (-100 ... +100)
TACN in downward trend: price dove below 50-day moving average on November 10, 2026